Showing results (1-10 of 48) with videos related to
Sort By:
Pageof 5
Clinical and Experimental Pharmacology & Physiology|October 9, 2002
Why do neuroprotective drugs that are so promising in animals fail in the clinic? An industry perspectiveA Richard GreenCritical Reviews in Neurobiology|December 8, 2004
Protecting the brain: the search for a clinically effective neuroprotective drug for strokeA Richard GreenTrends in Pharmacological Sciences|February 7, 2006
A brief history of British Pharmacological Society meetingsA Richard GreenBritish Journal of Pharmacology|January 13, 2006
Neuropharmacology of 5-hydroxytryptamineA Richard GreenDrug Discovery Today|July 19, 2006
Therapeutic strategies for the treatment of strokeA Richard Green, Ashfaq ShuaibCurrent Drug Targets. CNS and Neurological Disorders|April 29, 2005
Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengersA Richard Green, Tim AshwoodBritish Journal of Clinical Pharmacology|February 25, 2012
From basic to clinical neuropharmacology: targetophilia or pharmacodynamics?A Richard Green, Jeffrey K AronsonBritish Journal of Clinical Pharmacology|June 4, 2019
The British Pharmacological Society's WDM Paton Memorial Lecture 2019: How doctors were informed about pharmaceutical products through advertising in the British Medical Journal from 1955/6 to 1985/6Jeffrey K Aronson, A Richard GreenJournal of Psychopharmacology (Oxford, England)|March 29, 2014
Pharmacology should be at the centre of all preclinical and clinical studies on new psychoactive substances (recreational drugs)A Richard Green, David J NuttACS Chemical Neuroscience|January 22, 2013
How do we re-engage the pharmaceutical industry in research on serotonin and psychiatric disorders?A Richard Green, Charles A MarsdenPageof 5